| Description | Valrocemide (TV1901), also known as TV-1901, is an antiepileptic drug (AED). Valrocemide has a broad spectrum of anticonvulsant activity and promising potential as a new AED. Valrocemide is an anticonvulsant agent under development by Teva and Acorda as a potential therapeutic for the treatment of epilepsy. |
| Synonyms | TV1901, N-丙戊酰基甘氨酰胺, N-Valproylglycinamide, 丙戊塞胺 |
| molecular weight | 200.28 |
| Molecular formula | C10H20N2O2 |
| CAS | 92262-58-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | DMSO: 100 mg/mL (499.30 mM) |
| References | 1. Müller T,et al. CPI-1189. Centaur. Curr Opin Investig Drugs. 2002 Dec;3(12):1763-7. |